BridgeMD
Tests treatment safety and results for Diabetic Peripheral Neuropathic Pain (DPNP)
Official title Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
ClinicalTrials.gov ID: NCT07451431
What this study is testing
What is Mirogabalin?
Mirogabalin is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for diabetic peripheral neuropathic pain (dpnp).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if drug Mirogabalin works to treat diabetic peripheral neuropathic pain in adults. It will also learn about the safety of the drug Mirogabalin.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Adults (≥40 years) with diabetic neuropathy (Toronto score ≥6).
- Persistent pain (NPS) despite standard therapy.
- Stable diabetes management (HbA1c ≤8.5%).
You likely can't join if
- History of drug allergy to gabapentinoids.
- Concurrent use of opioids or other neuropathic pain medications.
- Pregnancy or lactation.
- Cancer pain
- Entraptment Radioculopathy
The study team makes the final eligibility decision.
Where it's taking place
- Dhaka, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dhaka, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.